| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/09/1994 | EP0581883A1 Blood substitutes and organ preservative solutions |
| 02/09/1994 | EP0581880A1 Process for making whey-derived fat substitute product and products thereof |
| 02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 02/09/1994 | EP0581849A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 02/09/1994 | EP0581842A1 An organ specific emulsion |
| 02/09/1994 | EP0366770B1 Liposomes coupled to hormones |
| 02/08/1994 | US5284941 Process for obtaining glycolipids and phospholipids |
| 02/08/1994 | US5284833 Aqueous solution or dry concentrate of a surfactant, an osmotic adjuster and a buffer; nontoxic; biocompatability |
| 02/08/1994 | US5284831 Boron neutron capture therapy |
| 02/08/1994 | US5284761 Method of encapsulating cells in a tubular extrudate |
| 02/08/1994 | US5284663 Artificial blood substitute; Lewis acid-Lewis base salt with perfluorocarbon encapsulated therein |
| 02/08/1994 | US5284662 Core of carbamazepine, crystal habit modifiers, hydroxyalkyl c celluloses, sugar alcohol, and mono- or disacdaride, semipermeable wall and hole in wall |
| 02/08/1994 | US5284660 Delayed onset transdermal delivery device |
| 02/08/1994 | US5284659 Time-release drug delivery |
| 02/08/1994 | US5284658 Means for constraining a rumen drug delivery device in a rolled configuration |
| 02/08/1994 | US5284657 Oligopeptide in cosolvent system fo alcohol and transport enhancing essential oil or acid |
| 02/08/1994 | US5284656 Pulmonary administration of granulocyte colony stimulating factor |
| 02/08/1994 | US5284645 Stable, biocompatible |
| 02/08/1994 | US5284588 Method and system for allowing increased migration across a lipid bilayer |
| 02/08/1994 | CA1326826C Soap based gel sticks |
| 02/08/1994 | CA1326824C External agent for the skin comprising a specific ethylenic copolymer |
| 02/08/1994 | CA1326821C Generic zero order controlled drug delivery system |
| 02/08/1994 | CA1326817C Promotion of healing of meniscal tissue |
| 02/08/1994 | CA1326816C Water-insolubilized cytokines |
| 02/08/1994 | CA1326791C Dressings |
| 02/06/1994 | CA2101680A1 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 02/04/1994 | CA2101126A1 Preparation for local treatment |
| 02/03/1994 | WO1994002674A1 Laminated dual textured treatment pads |
| 02/03/1994 | WO1994002518A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 02/03/1994 | WO1994002517A1 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| 02/03/1994 | WO1994002198A1 Time release bolus |
| 02/03/1994 | WO1994002178A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | WO1994002176A1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
| 02/03/1994 | WO1994002170A1 Oral administration of antigens |
| 02/03/1994 | WO1994002164A1 Granulocyte colony-stimulating factor solution delivery method |
| 02/03/1994 | WO1994002151A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-β-OESTRADIOL (ANHYDROUS) |
| 02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | WO1994002147A1 Water-dispersible tablets |
| 02/03/1994 | WO1994002146A1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/03/1994 | WO1994002141A1 Injection and injection kit containing omeprazole and its analogs |
| 02/03/1994 | WO1994002140A1 Pharmaceutical composition containing antiulcer agent |
| 02/03/1994 | WO1994002129A1 Veterinary medicinal anthelmintic preparation containing nitroscanate |
| 02/03/1994 | WO1994002127A1 A method of increasing creatine supply depot |
| 02/03/1994 | WO1994002123A1 Patch for low-melting and/or volatile active substances |
| 02/03/1994 | WO1994002122A1 Lymphatic delivery composition |
| 02/03/1994 | WO1994002121A1 Cross-linked polyhydroxylic material for enzymatically controlled drug release |
| 02/03/1994 | WO1994002119A1 Percutaneously administrable base composition and drug composition prepared therefrom |
| 02/03/1994 | WO1994002113A1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 02/03/1994 | WO1994002106A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | WO1994002029A1 Glucomannan spongeous matrices |
| 02/03/1994 | DE4301783C1 Transdermal system per admin. of galanthamine - esp. for treatment of Alzheimer's disease and alcohol addiction |
| 02/03/1994 | DE4230589C1 Dosierverfahren für leicht flüchtige oder thermolabile Substanzen in flüssiger Form zur Herstellung von ua flächigen Arzneiformen, insbesondere zur Herstellung von transdermalen oder dermalen therapeutischen Systemen Dosing for volatile or thermolabile substances in liquid form for the preparation of, inter alia, flat drug forms, in particular for the production of transdermal or dermal therapeutic systems |
| 02/03/1994 | DE4225489A1 Aq. eye-drops contg. adhesive bio-polymer, e.g. polyvinyl alcohol and acid - adhere well to the cornea, provide better and longer lasting delivery of active ingredient e.g. pilocarpine |
| 02/03/1994 | DE4225045A1 Verwendung von wasserlöslichen oder in Wasser dispergierbaren Polyurethanen als Hilfsmittel in kosmetischen und pharmazeutischen Zubereitungen und Polyurethane, die Polymilchsäurepolyole einpolymerisiert enthalten Contain polymerized using water-soluble or water-dispersible polyurethanes as auxiliaries in cosmetic and pharmaceutical preparations and polyurethanes Polymilchsäurepolyole |
| 02/03/1994 | DE4218292C1 Verwendung eines Arzneimittels mit einem Gehalt an Mestanolon und/oder 4-Chlor-1-dehydromethyltestosteron Use of a pharmaceutical having a content of mestanolone and / or 4-chloro-1-dehydromethyltestosteron |
| 02/03/1994 | CA2141216A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | CA2141193A1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 02/03/1994 | CA2140915A1 Laminated dual textured treatment pads |
| 02/03/1994 | CA2140901A1 Basal drug composition for percutaneous administration and pharmaceutical composition thereof |
| 02/03/1994 | CA2140864A1 Glucomannan spongeous matrices |
| 02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | CA2140445A1 Procede d'administration de solutions de facteur de stimulation des colonies granulocytaires |
| 02/03/1994 | CA2140333A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/02/1994 | EP0581676A2 Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| 02/02/1994 | EP0581587A2 Base for transdermal administration |
| 02/02/1994 | EP0581581A2 Bioadhesive treatment compositions and methods of use |
| 02/02/1994 | EP0581282A1 Use of lipid-bound glycosaminoglyrans for the treatment of rheumatoid arthritis |
| 02/02/1994 | EP0581057A1 Pharmaceutical semi-solid topical dosage unit forms for transdermal therapy |
| 02/02/1994 | EP0580862A1 Rapidly soluble solid preparation |
| 02/02/1994 | EP0580861A1 Capsule |
| 02/02/1994 | EP0580860A1 Method of manufacturing solid dispersion |
| 02/02/1994 | EP0580778A1 Convertible microemulsion formulations |
| 02/02/1994 | EP0580726A1 Low density microspheres and their use as contrast agents for computed tomography |
| 02/02/1994 | EP0580689A1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material. |
| 02/02/1994 | EP0580658A1 Nabumetone powders |
| 02/02/1994 | EP0580627A1 Pharmaceutical composition for the treatment of gastritis |
| 02/02/1994 | EP0580620A1 Stable multiple emulsions |
| 02/02/1994 | EP0523183B1 Microspheres, a preparation method therefor and uses thereof |
| 02/02/1994 | EP0464077B1 Process for the preparation of a ligand-receptor complex |
| 02/02/1994 | EP0442958B1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
| 02/02/1994 | EP0343233B1 Supercritical fluid reverse micelle separation |
| 02/02/1994 | EP0244444B1 Magnetic-polymer particles |
| 02/02/1994 | CN1081365A Method for pren. of fluorodine acid injection liquid |
| 02/01/1994 | US5283238 Methods of treating cancer using modified C-reactive protein |
| 02/01/1994 | US5283236 Systemic delivery of polypeptides through the eye |
| 02/01/1994 | US5283187 Cell culture-containing tubular capsule produced by co-extrusion |
| 02/01/1994 | US5283185 Mixing aqueous dispersion of cationic lipid and co-lipid with nucleic acids to form complex, incubating cells with complex |
| 02/01/1994 | US5283122 Solution containing fatty acid and cephalin |
| 02/01/1994 | US5283067 Freeze drying |
| 02/01/1994 | US5283066 Method of stimulating an immune response by using a hapten |
| 02/01/1994 | US5283065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| 02/01/1994 | US5283064 Large intestinal dissociative hard capsules |
| 02/01/1994 | US5283056 Transparent oil-in-water microemulsion flavor or fragrance concentrate, process for preparing same, mouthwash or perfume composition containing said transparent microemulsion concentrate, and process for preparing same |
| 02/01/1994 | US5282971 Cationic polymers having quaternary ammonium group covalently bonded to membrane surface as graft copolymers; permselectivity |
| 02/01/1994 | CA2101496A1 Base for transdermal administration |
| 01/31/1994 | CA2141404A1 Combinations of an organic nitrate and a salicylate |
| 01/31/1994 | CA2101482A1 Antirheumatic composition |
| 01/30/1994 | CA2101620A1 Amphiphilic sulfuretted, fluorinated and polyglycerol compounds, cosmetic or pharmaceutical composition containing them, preparation process and vesicles formed |
| 01/30/1994 | CA2101008A1 Bioadhesive treatment compositions and method of use |
| 01/27/1994 | DE4224401A1 New biodegradable homo- and co-polymer(s) for pharmaceutical use - produced by polycondensation of prod. from heterolytic cleavage of aliphatic polyester with functionalised (cyclo)aliphatic cpd. |